BRISTOL-MYERS SQUIBB CO (BMY) Stock Fundamental Analysis
USA - New York Stock Exchange - NYSE:BMY - US1101221083 - Common Stock
55.26 USD
-1.36 (-2.4%)
55.2101 USD
-0.05 (-0.09%)
BMY gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 191 industry peers in the Pharmaceuticals industry. While BMY belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health. BMY is valued quite cheap, while showing a decent growth score. This is a good combination! Finally BMY also has an excellent dividend rating. These ratings would make BMY suitable for value and dividend investing!
1. Profitability
1.1 Basic Checks
- In the past year BMY was profitable.
- In the past year BMY had a positive cash flow from operations.
- In multiple years BMY reported negative net income over the last 5 years.
- BMY had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
- BMY has a better Return On Assets (6.23%) than 87.50% of its industry peers.
- BMY has a better Return On Equity (32.55%) than 94.79% of its industry peers.
- BMY's Return On Invested Capital of 18.43% is amongst the best of the industry. BMY outperforms 95.83% of its industry peers.
- BMY had an Average Return On Invested Capital over the past 3 years of 12.30%. This is in line with the industry average of 12.84%.
- The last Return On Invested Capital (18.43%) for BMY is above the 3 year average (12.30%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 6.23% | ||
| ROE | 32.55% | ||
| ROIC | 18.43% |
ROA(3y)1.77%
ROA(5y)0.82%
ROE(3y)-2.38%
ROE(5y)-2.3%
ROIC(3y)12.3%
ROIC(5y)10.36%
1.3 Margins
- Looking at the Profit Margin, with a value of 12.57%, BMY belongs to the top of the industry, outperforming 84.90% of the companies in the same industry.
- The Operating Margin of BMY (33.51%) is better than 95.31% of its industry peers.
- In the last couple of years the Operating Margin of BMY has declined.
- BMY has a Gross Margin of 73.15%. This is amongst the best in the industry. BMY outperforms 80.73% of its industry peers.
- In the last couple of years the Gross Margin of BMY has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 33.51% | ||
| PM (TTM) | 12.57% | ||
| GM | 73.15% |
OM growth 3Y-0.56%
OM growth 5Y-4.29%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.73%
GM growth 5Y1.42%
2. Health
2.1 Basic Checks
- With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), BMY is creating value.
- The number of shares outstanding for BMY has been reduced compared to 1 year ago.
- Compared to 5 years ago, BMY has less shares outstanding
- The debt/assets ratio for BMY is higher compared to a year ago.
2.2 Solvency
- BMY has an Altman-Z score of 2.25. This is not the best score and indicates that BMY is in the grey zone with still only limited risk for bankruptcy at the moment.
- The Altman-Z score of BMY (2.25) is comparable to the rest of the industry.
- The Debt to FCF ratio of BMY is 3.20, which is a good value as it means it would take BMY, 3.20 years of fcf income to pay off all of its debts.
- Looking at the Debt to FCF ratio, with a value of 3.20, BMY belongs to the top of the industry, outperforming 88.02% of the companies in the same industry.
- BMY has a Debt/Equity ratio of 2.41. This is a high value indicating a heavy dependency on external financing.
- BMY's Debt to Equity ratio of 2.41 is on the low side compared to the rest of the industry. BMY is outperformed by 79.17% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 2.41 | ||
| Debt/FCF | 3.2 | ||
| Altman-Z | 2.25 |
ROIC/WACC2.09
WACC8.82%
2.3 Liquidity
- BMY has a Current Ratio of 1.27. This is a normal value and indicates that BMY is financially healthy and should not expect problems in meeting its short term obligations.
- With a Current ratio value of 1.27, BMY is not doing good in the industry: 78.13% of the companies in the same industry are doing better.
- A Quick Ratio of 1.17 indicates that BMY should not have too much problems paying its short term obligations.
- BMY has a Quick ratio of 1.17. This is in the lower half of the industry: BMY underperforms 76.04% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.27 | ||
| Quick Ratio | 1.17 |
3. Growth
3.1 Past
- The Earnings Per Share has grown by an impressive 460.68% over the past year.
- Measured over the past years, BMY shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -24.57% on average per year.
- Looking at the last year, BMY shows a small growth in Revenue. The Revenue has grown by 1.26% in the last year.
- Measured over the past years, BMY shows a quite strong growth in Revenue. The Revenue has been growing by 13.06% on average per year.
EPS 1Y (TTM)460.68%
EPS 3Y-46.63%
EPS 5Y-24.57%
EPS Q2Q%-9.44%
Revenue 1Y (TTM)1.26%
Revenue growth 3Y1.36%
Revenue growth 5Y13.06%
Sales Q2Q%2.77%
3.2 Future
- The Earnings Per Share is expected to grow by 35.29% on average over the next years. This is a very strong growth
- Based on estimates for the next years, BMY will show a decrease in Revenue. The Revenue will decrease by -5.06% on average per year.
EPS Next Y478.44%
EPS Next 2Y130.59%
EPS Next 3Y73.3%
EPS Next 5Y35.29%
Revenue Next Year0.23%
Revenue Next 2Y-3.95%
Revenue Next 3Y-3.2%
Revenue Next 5Y-5.06%
3.3 Evolution
- The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
- When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
- With a Price/Earnings ratio of 8.42, the valuation of BMY can be described as very reasonable.
- BMY's Price/Earnings ratio is rather cheap when compared to the industry. BMY is cheaper than 92.19% of the companies in the same industry.
- When comparing the Price/Earnings ratio of BMY to the average of the S&P500 Index (27.38), we can say BMY is valued rather cheaply.
- With a Price/Forward Earnings ratio of 9.12, the valuation of BMY can be described as very reasonable.
- 89.06% of the companies in the same industry are more expensive than BMY, based on the Price/Forward Earnings ratio.
- The average S&P500 Price/Forward Earnings ratio is at 24.29. BMY is valued rather cheaply when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 8.42 | ||
| Fwd PE | 9.12 |
4.2 Price Multiples
- Based on the Enterprise Value to EBITDA ratio, BMY is valued cheaper than 92.71% of the companies in the same industry.
- BMY's Price/Free Cash Flow ratio is rather cheap when compared to the industry. BMY is cheaper than 94.79% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 7.35 | ||
| EV/EBITDA | 6.85 |
4.3 Compensation for Growth
- The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
- BMY has a very decent profitability rating, which may justify a higher PE ratio.
- A more expensive valuation may be justified as BMY's earnings are expected to grow with 73.30% in the coming years.
PEG (NY)0.02
PEG (5Y)N/A
EPS Next 2Y130.59%
EPS Next 3Y73.3%
5. Dividend
5.1 Amount
- BMY has a Yearly Dividend Yield of 4.45%, which is a nice return.
- Compared to an average industry Dividend Yield of 0.40, BMY pays a better dividend. On top of this BMY pays more dividend than 97.40% of the companies listed in the same industry.
- BMY's Dividend Yield is rather good when compared to the S&P500 average which is at 1.85.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 4.45% |
5.2 History
- On average, the dividend of BMY grows each year by 11.67%, which is quite nice.
- BMY has been paying a dividend for at least 10 years, so it has a reliable track record.
- BMY has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)11.67%
Div Incr Years3
Div Non Decr Years3
5.3 Sustainability
- 82.81% of the earnings are spent on dividend by BMY. This is not a sustainable payout ratio.
- BMY's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP82.81%
EPS Next 2Y130.59%
EPS Next 3Y73.3%
55.26
-1.36 (-2.4%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)10-30 2025-10-30/bmo
Earnings (Next)02-05 2026-02-05/amc
Inst Owners81.87%
Inst Owner Change0.12%
Ins Owners0.02%
Ins Owner Change-1.33%
Market Cap112.50B
Revenue(TTM)48.03B
Net Income(TTM)6.04B
Analysts70
Price Target56.91 (2.99%)
Short Float %1.74%
Short Ratio2.18
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 4.45% |
Yearly Dividend2.42
Dividend Growth(5Y)11.67%
DP82.81%
Div Incr Years3
Div Non Decr Years3
Ex-Date01-02 2026-01-02 (0.63)
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)20.98%
Min EPS beat(2)6.92%
Max EPS beat(2)35.04%
EPS beat(4)4
Avg EPS beat(4)18.72%
Min EPS beat(4)6.92%
Max EPS beat(4)35.04%
EPS beat(8)8
Avg EPS beat(8)16.52%
EPS beat(12)11
Avg EPS beat(12)11.66%
EPS beat(16)15
Avg EPS beat(16)10.13%
Revenue beat(2)2
Avg Revenue beat(2)4.61%
Min Revenue beat(2)2.43%
Max Revenue beat(2)6.79%
Revenue beat(4)4
Avg Revenue beat(4)4.63%
Min Revenue beat(4)2.43%
Max Revenue beat(4)6.79%
Revenue beat(8)8
Avg Revenue beat(8)3.95%
Revenue beat(12)9
Avg Revenue beat(12)1.94%
Revenue beat(16)11
Avg Revenue beat(16)1.64%
PT rev (1m)6.03%
PT rev (3m)8.15%
EPS NQ rev (1m)-2.77%
EPS NQ rev (3m)1.7%
EPS NY rev (1m)-0.19%
EPS NY rev (3m)0.14%
Revenue NQ rev (1m)0.05%
Revenue NQ rev (3m)1.81%
Revenue NY rev (1m)0.05%
Revenue NY rev (3m)1.36%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 8.42 | ||
| Fwd PE | 9.12 | ||
| P/S | 2.34 | ||
| P/FCF | 7.35 | ||
| P/OCF | 6.77 | ||
| P/B | 6.06 | ||
| P/tB | N/A | ||
| EV/EBITDA | 6.85 |
EPS(TTM)6.56
EY11.87%
EPS(NY)6.06
Fwd EY10.97%
FCF(TTM)7.52
FCFY13.6%
OCF(TTM)8.16
OCFY14.77%
SpS23.6
BVpS9.11
TBVpS-11.62
PEG (NY)0.02
PEG (5Y)N/A
Graham Number36.68
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 6.23% | ||
| ROE | 32.55% | ||
| ROCE | 23.41% | ||
| ROIC | 18.43% | ||
| ROICexc | 24.22% | ||
| ROICexgc | 123.43% | ||
| OM | 33.51% | ||
| PM (TTM) | 12.57% | ||
| GM | 73.15% | ||
| FCFM | 31.86% |
ROA(3y)1.77%
ROA(5y)0.82%
ROE(3y)-2.38%
ROE(5y)-2.3%
ROIC(3y)12.3%
ROIC(5y)10.36%
ROICexc(3y)14.46%
ROICexc(5y)12.33%
ROICexgc(3y)78.95%
ROICexgc(5y)80.83%
ROCE(3y)15.62%
ROCE(5y)13.15%
ROICexgc growth 3Y-16.88%
ROICexgc growth 5Y3.18%
ROICexc growth 3Y7.41%
ROICexc growth 5Y19.82%
OM growth 3Y-0.56%
OM growth 5Y-4.29%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.73%
GM growth 5Y1.42%
F-Score6
Asset Turnover0.5
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 2.41 | ||
| Debt/FCF | 3.2 | ||
| Debt/EBITDA | 2.13 | ||
| Cap/Depr | 26.84% | ||
| Cap/Sales | 2.75% | ||
| Interest Coverage | 7.66 | ||
| Cash Conversion | 79.11% | ||
| Profit Quality | 253.39% | ||
| Current Ratio | 1.27 | ||
| Quick Ratio | 1.17 | ||
| Altman-Z | 2.25 |
F-Score6
WACC8.82%
ROIC/WACC2.09
Cap/Depr(3y)12.09%
Cap/Depr(5y)10.53%
Cap/Sales(3y)2.56%
Cap/Sales(5y)2.31%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)460.68%
EPS 3Y-46.63%
EPS 5Y-24.57%
EPS Q2Q%-9.44%
EPS Next Y478.44%
EPS Next 2Y130.59%
EPS Next 3Y73.3%
EPS Next 5Y35.29%
Revenue 1Y (TTM)1.26%
Revenue growth 3Y1.36%
Revenue growth 5Y13.06%
Sales Q2Q%2.77%
Revenue Next Year0.23%
Revenue Next 2Y-3.95%
Revenue Next 3Y-3.2%
Revenue Next 5Y-5.06%
EBIT growth 1Y44.7%
EBIT growth 3Y0.79%
EBIT growth 5Y8.21%
EBIT Next Year263.97%
EBIT Next 3Y49.92%
EBIT Next 5Y23.19%
FCF growth 1Y30.91%
FCF growth 3Y-2.91%
FCF growth 5Y14.03%
OCF growth 1Y28.71%
OCF growth 3Y-2.14%
OCF growth 5Y13.49%
BRISTOL-MYERS SQUIBB CO / BMY FAQ
What is the ChartMill fundamental rating of BRISTOL-MYERS SQUIBB CO (BMY) stock?
ChartMill assigns a fundamental rating of 6 / 10 to BMY.
What is the valuation status for BMY stock?
ChartMill assigns a valuation rating of 9 / 10 to BRISTOL-MYERS SQUIBB CO (BMY). This can be considered as Undervalued.
What is the profitability of BMY stock?
BRISTOL-MYERS SQUIBB CO (BMY) has a profitability rating of 7 / 10.
Can you provide the financial health for BMY stock?
The financial health rating of BRISTOL-MYERS SQUIBB CO (BMY) is 5 / 10.
What is the expected EPS growth for BRISTOL-MYERS SQUIBB CO (BMY) stock?
The Earnings per Share (EPS) of BRISTOL-MYERS SQUIBB CO (BMY) is expected to grow by 478.44% in the next year.